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Aims The aim of this study is to show the feasibility of a biventricular implantable cardioverter-deﬁbrillator [cardiac resyn-
chronization therapy (CRT)–ICD] implantation using an electroanatomic navigation system and a low dose of ﬂuoro-
scopy. Here four case reports of patients affected by dilated cardiomyopathy, who underwent cardiac
resynchronization therapy, are described.
Methods
and results
During 2010, four patients were admitted to our Cardiology Department for implantation of an CRT–ICD device
in primary prevention. All had an ejection fraction of ,35% and were in New York Heart Association class III
despite optimal medical therapy. The implantations were performed using the EnSite NavX system. All the
leads were positioned in the cardiac chambers utilizing the three-dimensional navigation system and only using
X-ray to check that the leads had been positioned correctly. To our knowledge, these cases are the ﬁrst use
of an electroanatomic system for implantation of an CRT–ICD device and in all four cases the cannulation of
the coronary sinus (CS) was performed only using the mapping system. Electroanatomic navigation made it poss-
ible to minimize X-ray exposure during the implantation of the CRT–ICD device; in addition, the mapping system
was used to choose the optimum position of the CS catheter using as reference the maximum activation delay
between the two ventricles.
Conclusions The NavX system shows great potential during the implantation of an CRT–ICD device. It seems to be feasible, safe,
and extremely beneﬁcial in terms of a reduction in X-ray exposure. Furthermore, there is beneﬁt of more detailed
information and accuracy during the CS lead placement.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Thetransvenousimplantationofdevices,suchaspacemakersanddeﬁ-
brillators,isusuallyperformedwiththeaidofﬂuoroscopyasthestan-
dard tool for visualization of the leads in the cardiac chambers. This
implies radiation exposure for patients and operators. Furthermore,
ﬂuoroscopy allows only a two-dimensional (2D) view of catheter
movements, making it difﬁcult to position catheters in the complex
anatomyofcardiacstructures.Recently,systemsfornon-ﬂuoroscopic
3D catheter navigation through the cardiac chambers and vascular
structures have been developed
1–3 and there are some cases,
4,5
reported in literature, demonstrating the possibility of implanting
pacemakers using these tools and without the use of ﬂuoroscopy.
Ouraimwastostudythefeasibilityandreliabilityofimplantingathree-
lead system [biventricular implantable cardioverter-deﬁbrillator—
cardiacresynchronizationtherapy–implantablecardioverter-deﬁbril-
lator (CRT–ICD) device] guided by an electroanatomic navigation
system, which would minimize ﬂuoroscopy use and focus on the
evaluation of coronary sinus (CS) vessels.
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During 2010 four patients were admitted to our Cardiology Depart-
ment for implantation of an CRT–ICD device in primary prevention.
Three patients were affected by ischaemic cardiomyopathy and one
by non-ischaemic cardiomyopathy. All had an ejection fraction of
,35% and were in New York Heart Association (NYHA) class III
despite optimal medical therapy. Table 1 summarizes the clinical
characteristics of the patients as well as the procedure times, the
ﬂuoroscopy times, the parameters obtained at implant, and the make
of the device.
The implantation was performed using the EnSite NavX system
(St Jude Medical, Endocardial Solutions Inc., St Paul, MN, USA).
Three pairs of adhesive electrodes were placed on the chest of
each of the patients conﬁguring orthogonal axes and a low-power
5.7 kHz electrical potential was generated across each pair of electro-
des (as previously reported in the paper by Ruiz-Granell et al.
5 pub-
lished in Europace). The voltage gradient from each axis helps to
generate a 3D navigation ﬁeld. After the electrodes’ size and the
inter-electrode spacing has been chosen for each of the catheters,
the EnSite system can be used to create geometric models of the
patient’s cardiac chambers and show in real-time a 3D image of the
catheters’ location. The EnSite NavX system can be also used to
measure the distance between points on the geometric model of
the endocardial surface, using the Field Scaling algorithm. Field
Scaling is based on geometrical points collected in continuous
mode by catheters with deﬁned inter-electrode spacing. Adjustments
to the dimensions of the navigation ﬁeld are made considering the
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Table 1 Clinical characteristics of the patients, procedure times, ﬂuoroscopy times and parameters obtained at implant
and the make of the device.
Case 1 Case 2 Case 3 Case 4
Sex M M M F
Age 49 79 80 77
Ejection fraction (%) 20 34 18 32
Cardiomyopathy Ischaemic Ischaemic Ischaemic Non-ischaemic
Cardiac rhythm Atrial ﬁbrillation Sinus rhythm Sinus rhythm Sinus rhythm
Bundle branch block Right bundle branch block (QRS
duration ¼ 154 ms)
Bifascicular block (QRS
duration ¼ 164 ms)
Left bundle branch block (paced
QRS duration ¼ 174 ms)
Leftbundlebranchblock
(QRS
duration ¼ 164 ms)
Other features AV node ablation after
CRT–ICD implantation
Dual chamber pacemaker carrier
before CRT–ICD
implantation
Parameters obtained at implant
RV-wave amplitude 9.1 mV 14.2 mV 12.5 mV 9.1 mV
RV lead impedance 955 V at 5.0 V 1156 V at 5.0 V 738 V at 5.0 V 656 V at 5.0 V
RV threshold 0.4 V at 0.5 ms 0.4 V at 0.5 ms 0.4 V a 0.5 ms 0.5 V at 0.5 ms
RV lead position Apex Apex Mid-septum Apex
P-wave amplitude 0.9 ms 3.1 mV 3.5 mV 2.2 mV
P lead impedance not determined 530 V at 5.0 V 479 V at 5.0 V 528 V at 5.0 V
P threshold not determined 1.2 V at 0.5 ms 4.5 V at 1.6 ms 1.3 V at 0.5 ms
LV-wave amplitude 19.9 mV 9.3 mV 10.1 mV 1.2 mV
LV impedance 769 V at 5.0 V 1308 V at 5.0 V 1027 V at 5.0 V 475 V at 5.0 V
LV threshold 0.3 V at 0.5 ms 2.0 V at 0.5 ms 0.3 V at 0.5 ms 1.9 V at 0.5 ms
Target vein forCS lead Posterior vein Anterior vein Lateral vein Lateral vein
LV lead postion Distal Distal Proximal Mid
Manufacturers of the
ICD
Boston scientiﬁc livian REF H247 Boston scientiﬁc livian REF H247 Boston scientiﬁc livian REF H247 Medtronic consulta
D234TRK
Bipolar ICD lead Guidant Endotak Reliance G REF
0175 (passive ﬁxation, double
coil)
Guidant Endotak Reliance G REF
0175 (passive ﬁxation, double
coil)
Guidant Endotak Reliance SG
REF 0181 (active ﬁxation,
single coil)
Medtronic 6935 (active
ﬁxation, single coil)
Bipolar left lead Guidant Easytrak 2 REF 4542 Guidant Easytrak 2 REF 4543 Guidant Easytrak 2 REF 4542 Medtronic 4194
Bipolar atrial lead Guidant, Fineline 2 (passive
ﬁxation) REF 4480
Guidant, Fineline 2 (passive
ﬁxation) REF 4480
Medtronic 4592 (passive
ﬁxation)
Medtronic 5594 (passive
ﬁxation)
Total time for
implantation (min)
168 142 130 124
Length of radiation
exposure (DAP)
16.8 min (2914 cGy×cm
2) 16.9 min (3984 cGy×cm
2) 7.3 min (3946 cGy×cm
2) 4.2 min
(1089 cGy×cm
2)
AV, atrioventricular; RV, right ventricle; LV, left ventricle; CS, coronary sinus; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-deﬁbrillator; DAP, dose area
product.
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geometry of the 3D model.
The same experienced cardiologist performed all four procedures.
Under local anaesthesia with lidocaine, the left subclavian vein was
cannulated three times in order to introduce three different wires.
The implantation method was always performed as follows:
† First, a bipolar ICD right ventricular lead connected to the NavX
system was introduced through a 9F sheath and used to map refer-
ence points for the superior vena cava, and then to create a rough
3D model of the right atrium and the right ventricle. After the 3D
model had been created, the lead tip was positioned in the apex of
the right ventricle and a shadow was registered to check that it
remained in its position during the rest of the procedure. The pos-
ition was also conﬁrmed by a 12-lead electrocardiogram (paced
QRS complex morphology) and by a single shot of ﬂuoroscopy.
Only in one case (Case 3), the ICD lead was positioned in the
mid-septum of the right ventricle (active ﬁxation) due to the pres-
ence of a pacemaker lead in the apex from a prior implantation.
† Second, a 5F quadripolar electrophysiological catheter, connected
to the NavX system, was introduced through the left subclavian
vein using a 10F valved sheath. The electrophysiological catheter
was introduced via the delivery system and was used to cannulate
and to map the CS without resorting to ﬂuoroscopy and it was
also used to complete the 3D model of the right atrium
(see Figure 1). Short bursts of ﬂuoroscopy were used to check
the position of the CS and perform CS angiography. Then, the elec-
trophysiological catheter was withdrawn leaving the delivery system
in the CS and through this a bipolar left ventricular lead was
immediately inserted. With small movements of the left ventricular
lead, connected to the NavX, it was possible to create the 3D map
of the CS branches following the CS angiography imaging. When
necessary, especially for the smallest vessels, wire incannulation
was performed using ﬂuoroscopy. However, for the subsequent
selective lead introduction the NavX system was used. During
vessel mapping, a number of points were collected and the local
ventricular activation time and the bipolar voltage amplitude were
recorded on the map during sinus rhythm. The right ventricular
electrogram was used as reference during the NavX activation
map. The ﬁnal position of the CS lead in the target vessel was
chosen ﬁrst in relation to the maximum activation delay between
the electrogram in the right ventricle and the electrogram in the
CS branch as shown on the activation map in Figure 2, but also
considering the following factors: stable lead position in the
vessel, absence of phrenic nerve stimulation, and an acceptable
pacing threshold. As is very often the case, the last three factors
led to some compromise in the choice of the ﬁnal CS lead position.
† Finally, the right atrial lead, connected to the NavX system, was
placed in the right auricle guided by the navigation system, which
at the same time continued to check on the location of the other
catheters and was used to help maintain their original position.
For each procedure the ﬂuoroscopy time, the Dose Area Product
(DAP), the time duration and all the lead pacing/sensing parameters
were recorded (see Table 1).
Results
All the leads were positioned in the cardiac chambers utilizing, for
the most part, the 3D navigation system and only using X-ray to
check that they had been positioned correctly (by means of a
very low number of oblique projections). It is worth noting that
in all the patients the CS was cannulated with the aid of NavX
Figure 1 Case 4. (A) The coronary sinus angiography performed with the Swan-Ganz catheter in a antero-posterior projection. The blue and
orange arrows indicate the coronary sinus and the presence of a lateral vein, respectively. This image also shows the presence of a bipolar
implantable cardioverter–deﬁbrillator lead placed in the apex of the right ventricle and it is possible to see the tip of a J-wire in the right
atrium. (B) Reconstruction of the right cardiac chambers, the superior and inferior vena cava and the coronary sinus using the NavX
system; the blue and orange arrows indicate the three-dimensional reconstruction of the coronary sinus and the lateral vein, respectively.
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reduction in ﬂuoroscopy time was observed from the 16.9 min
of the ﬁrst procedure to the 4.2 min of the last one suggesting
improved skill and familiarity with the use of the NavX system
for CRT–ICD implantation.
All the implantations were successful and the ﬁnal pacing/sensing
parameters ofthe three leads (see Table 1) were in thenormal range.
No complications were observed during the four procedures and
therewasnoevidenceofleaddislodgementthedayafterimplantation.
For all four patients, at the 3-month follow-up, the CRT–ICD device
wasfunctioningproperlywithadequatepacingandsensingthresholds
and each showed a typical biventricular stimulation at the electrocar-
diographic registration. All the patients moved up a NYHA class and
the physicians considered them CRT responders.
Discussion
There are a number of important aspects in this report:
† To our knowledge, these four cases are the ﬁrst use of an elec-
troanatomic navigation system for implantation of a CRT–ICD
device.
† In all four cases, the cannulation of the CS was performed only
using the mapping system and at the end of the manoeuvre a
single shot of ﬂuoroscopy was employed to conﬁrm the
correct placement of the delivery system.
† Reconstructing the complexities of the cardiac-vein anatomy
and guiding the catheter to the target CS vessel using the
electroanatomic navigation system proved to be feasible and
reliable.
† Throughout this approach, it was possible to check the position
of each lead at any time without the use of ﬂuoroscopy.
† The electroanatomic navigation system allowed us to minimize
X-ray exposure during the implantation of the CRT–ICD
device and in particular during the placement of the CS lead.
The mean total ﬂuoroscopy time for CRT–ICD implantation in
previous papers ranged from 23.9+18.1 min
6 to 46+23 min
7.
These four cases show that ﬂuoroscopy time decreased from
16.9 to 4.2 min and this may suggest that ‘near zero’ ﬂuoroscopy
use for CRT–ICD implantation is feasible. Furthermore, it
would seem that the learning curve for CRT–ICD implantation
using an electroanatomic navigation system, in centres with
experience with this technology for catheter ablation, is short
and easy.
Figure 2 (A) Final implantation of the cardiac resynchronization therapy–implantable cardioverter–deﬁbrillator device in an antero-posterior
projection and the arrows indicate the three-lead positions (blue arrow, right atrial lead; yellow arrow, right ventricular lead; and red arrow, left
ventricular lead). (B) The same view of the ﬁnal implantation of the cardiac resynchronization therapy–internal cardioverter-deﬁbrillator device
constructed using the NavX system. It is easy to appreciate how the two images correspond as regards the ﬁnal position of the leads. The
coronary sinus and the lateral vein in (B) also show the activation colour map of the left ventricle during sinus rhythm constructed using
NavX system; the purple colour indicates the position of the maximum delay of ventricular activation and therefore the best ﬁnal position
for the left lead. The insert shows the electrograms of the right and left ventricle recorded by the leads during sinus rhythm.
M. Del Greco et al. 110† The mapping system was used to choose the optimum position
of the CS lead in the target vessel using as reference the
maximum activation delay between the two ventricles. Pacing
the left ventricle at the most delayed site is now considered
a good marker for promoting contractile synchrony and
improving ejection fraction.
6,7
Conclusion
The use of an electroanatomic navigation system (NavX system) in
CRT–ICD implantation shows great potential. It seems to be feas-
ible and safe but the possibility of minimizing X-ray exposure both
for patients and physicians is the most attractive aspect.
Furthermore, there is the beneﬁt of more detailed information
and accuracy during the CS lead placement, both in terms of 3D
anatomy knowledge and ventricular activation time, which
optimize the pacing site choice. However, similar procedures
recounted in studies, case reports or ideally in randomized trials
and their reports, would be needed to conﬁrm the experience
detailed in this study.
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